ArticleRisk management and healthcare policy2021
The "Quarantine Dry Eye": The Lockdown for Coronavirus Disease 2019 and Its Implications for Ocular Surface Health.
Article in Risk management and healthcare policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.
- Prevalence of dry eye during the COVID-19 pandemic: A systematic review and meta-analysis.PloS one · 2023Pooled it
- Effects of remote learning during the COVID-19 lockdown on children's visual health: a systematic review.BMJ open · 2022Pooled it
- Omega-3 fatty acids supplements for dry eye - Are they effective or ineffective?Indian journal of ophthalmology · 2023Trial
- New healthcare insights in ophthalmology: using a data integration center (DIC) to analyze the care of patients with corneal ulceration during the COVID-19 pandemic.International ophthalmology · 2026Article
- Visual Functioning and Mental Health in the Digital Age.Journal of clinical medicine · 2025Review
- Dry Eye Disease: An Update on Changing Perspectives on Causes, Diagnosis, and Management.Cureus · 2024Review
- Prevalence and Risk Factors of Dry Eye Disease in the South of Palestine.The Malaysian journal of medical sciences : MJMS · 2024Article
- Real or MADE-up: Investigating Mask-Associated Dry Eye (MADE) as an emerging syndrome.Eye (London, England) · 2024Review
- Article
- Dry eye among medical students before and during COVID-19.Indian journal of ophthalmology · 2023Article
- Ocular Surface Changes Associated with Face Masks in Healthcare Personnel during COVID-19 Pandemic.Life (Basel, Switzerland) · 2022Article
- COVID-19 Long-Term Effects: Is There an Impact on the Simple Reaction Time and Alternative-Forced Choice on Recovered Patients?Brain sciences · 2022Article
- The Relationship between Religious Beliefs and Attitudes towards Public Health Infection Prevention Measures among an Ultra-Orthodox Jewish Population during the COVID-19 Pandemic.International journal of environmental research and public health · 2022Article
- Impact of COVID-19 pandemic on ophthalmic presentations to an Australian outer metropolitan and rural emergency department: a retrospective comparative study.BMC ophthalmology · 2022Article
- Update on overview of ocular manifestations of COVID-19.Frontiers in medicine · 2022Review
- Ocular and Systemic Complications of COVID-19: Impact on Patients and Healthcare.Clinical ophthalmology (Auckland, N.Z.) · 2022Review
- Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients Presenting with Conjunctivitis During the COVID-19 Pandemic.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- Short Tear Breakup Time Could Exacerbate the Progression of Presbyopia in Women.BioMed research international · 2022Article
- The Effect of Lockdown Due to the COVID-19 Pandemic on Digital Eye Strain Symptoms Among the General Population: A Cross-Sectional Survey.Frontiers in public health · 2022Article
- Coronavirus disease pandemic and dry eye disease: A methodology concern on the causal relationship.Medical hypothesis, discovery & innovation ophthalmology journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pandemic of coronavirus disease 2019 (COVID-19) has led many countries of the world to impose a series of containment measures such as lockdowns (mass quarantines), curfews or similar restrictions (eg, stay-at-home orders, or shelter-in-place orders). All these restrictions were established in order to limit spread of COVID-19. Thus, approximately 3.9 billion people worldwide were under lockdown by early April 2020. During this time (home confinement), some solutions have been proposed by experts to improve work and school productivity, including smart working and online school lessons. However, many of the restrictive measures are likely to act as predisposing factors for dry eye disease (DED), directly or related to sick building syndrome (SBS). Herein, we discuss the implications of quarantine measures on eye health, in particular on DED associated with SBS, and introduce some potential preventive strategies for lockdown-related ocular surface disorders. Several risk factors are implicated in their pathogenesis, including environmental changes (eg, air quality) and modifications in personal behaviors (eg, the abuse of digital devices, malnutrition, and sleep/psychiatric disorders). Considering a number of predisposing factors for DED, it is possible to state that patients under lockdown are at risk of ocular surface alterations. Accordingly, the COVID-19 pandemic era is expected to determine an increase in dry eye patients all around the world (a new phenomenon that we propose to name the "quarantine dry eye") in the event that the restrictive measures will be recursively extended over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.